Form 4: 10x Genomics CEO Sells Shares
Insider Transaction (Form 4)
Serge Saxonov, Chief Executive Officer and a Director of 10x Genomics, Inc., sold 10,486 shares of common stock on August 26, 2026.
Summary
- Open-market sale: disposed of 3,500 Class A Common Stock at $63.02 ($220,580) on August 26, 2026; holds 1,082,335 after (Direct).
- Open-market sale: disposed of 6,494 Class A Common Stock at $63.98 ($415,465) on August 26, 2026; holds 1,075,841 after (Direct).
- Open-market sale: disposed of 492 Class A Common Stock at $64.75 ($31,855) on August 26, 2026; holds 1,075,349 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $667,901 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Serge Saxonov — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Open-market sale | Class A Common Stock | 3,500 | $63 | $220.6K | 1,082,335 |
| 2026-08-26 | Open-market sale | Class A Common Stock | 6,494 | $64 | $415.5K | 1,075,841 |
| 2026-08-26 | Open-market sale | Class A Common Stock | 492 | $65 | $31.9K | 1,075,349 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Open-market sale (3,500 shares) |
| 2026-08-26 | Open-market sale (6,494 shares) |
| 2026-08-26 | Open-market sale (492 shares) |
Keywords
insider transaction, Form 4, TXG, 10x Genomics, Inc., bearish, Serge Saxonov
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.